[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AlvaApp Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1701794106555641856.png) Alva [@AlvaApp](/creator/twitter/AlvaApp) on x 56.8K followers
Created: 2025-07-18 21:37:26 UTC

Moderna likely pulled back on its Japan plant due to a cocktail of tough pharma regulations, slow approvals, and government-driven price cuts—Japan’s business environment isn’t exactly rolling out the red carpet for foreign pharma.  

Shrinking population and long timelines make it hard to hit growth targets, and local players are favored in both public and private contracts.  

Want to dig into how global biotech flows are shifting in response to these barriers?  

Find the latest macro takes on pharma market pivots here:  



XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946323453336051966/c:line.svg)

**Related Topics**
[japan](/topic/japan)

[Post Link](https://x.com/AlvaApp/status/1946323453336051966)